BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2966592)

  • 1. Hormonal determinants of sodium excretion in rats with experimental high-output heart failure.
    Winaver J; Hoffman A; Burnett JC; Haramati A
    Am J Physiol; 1988 May; 254(5 Pt 2):R776-84. PubMed ID: 2966592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of converting-enzyme inhibition on renal response to ANF in rats with experimental heart failure.
    Abassi Z; Haramati A; Hoffman A; Burnett JC; Winaver J
    Am J Physiol; 1990 Jul; 259(1 Pt 2):R84-9. PubMed ID: 2142862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Captopril enhances renal responsiveness to ANF in dogs with compensated high-output heart failure.
    Villarreal D; Freeman RH; Johnson RA
    Am J Physiol; 1992 Mar; 262(3 Pt 2):R509-16. PubMed ID: 1313653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial natriuretic peptide and renal cGMP in rats with experimental heart failure.
    Abassi Z; Burnett JC; Grushka E; Hoffman A; Haramati A; Winaver J
    Am J Physiol; 1991 Oct; 261(4 Pt 2):R858-64. PubMed ID: 1656791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Losartan improves the natriuretic response to ANF in rats with high-output heart failure.
    Abassi ZA; Kelly G; Golomb E; Klein H; Keiser HR
    J Pharmacol Exp Ther; 1994 Jan; 268(1):224-30. PubMed ID: 8301562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bradykinin does not modulate the natriuretic response to atrial natriuretic factor in rats with aortocaval fistula.
    Abassi ZA; Klein H; Cox J; Keiser HR
    Hypertension; 1993 Jun; 21(6 Pt 2):966-70. PubMed ID: 8505108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ANF and postprandial control of sodium excretion in dogs with compensated heart failure.
    Villarreal D; Freeman RH; Brands MW
    Am J Physiol; 1990 Jan; 258(1 Pt 2):R232-9. PubMed ID: 2137300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of atrial natriuretic factor in rats with experimental high-output heart failure.
    Hoffman A; Burnett JC; Haramati A; Winaver J
    Kidney Int; 1988 Mar; 33(3):656-61. PubMed ID: 2966872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DOCA administration and atrial natriuretic factor in dogs with chronic heart failure.
    Villarreal D; Freeman RH; Brands MW
    Am J Physiol; 1989 Sep; 257(3 Pt 2):H739-45. PubMed ID: 2528918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldosterone and renin inhibition by physiological levels of atrial natriuretic factor.
    Brands MW; Freeman RH
    Am J Physiol; 1988 Jun; 254(6 Pt 2):R1011-6. PubMed ID: 2968054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal and adrenal resistance against atrial natriuretic peptide in congestive heart failure: effect of angiotensin I-converting-enzyme inhibition.
    Wambach G; Schittenhelm U; Bönner G; Kaufmann W
    Cardiology; 1989; 76(6):418-27. PubMed ID: 2558792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldosterone and renin inhibition by atrial natriuretic factor in potassium-loaded rats.
    Brands MW; Freeman RH
    Am J Physiol; 1989 Dec; 257(6 Pt 2):R1423-8. PubMed ID: 2532482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial natriuretic factor-specific antibody as a tool for physiological studies. Evidence for role of atrial natriuretic factor in aldosterone and renal electrolyte regulation.
    Rudd MA; Plavin S; Hirsch AT; Ingelfinger JR; Dzau VJ
    Circ Res; 1989 Nov; 65(5):1324-9. PubMed ID: 2529999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of endogenous atrial natriuretic factor in acute congestive heart failure.
    Lee ME; Miller WL; Edwards BS; Burnett JC
    J Clin Invest; 1989 Dec; 84(6):1962-6. PubMed ID: 2531762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal changes in natriuretic and antinatriuretic systems after closure of a large arteriovenous fistula.
    Abassi ZA; Brodsky S; Karram T; Dobkin I; Winaver J; Hoffman A
    Cardiovasc Res; 2001 Aug; 51(3):567-76. PubMed ID: 11476747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of chronic infusion of atrial natriuretic factor on plasma and urinary aldosterone, plasma renin activity, blood pressure and sodium excretion in 2-K, 1-C hypertensive rats.
    Garcia R; Thibault G; Gutkowska J; Cantin M
    Clin Exp Hypertens A; 1986; 8(7):1127-47. PubMed ID: 2945679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of angiotensin converting enzyme inhibition on renal response to atrial natriuretic factor in rats.
    Wu JN; Huang WC
    Proc Natl Sci Counc Repub China B; 1988 Jul; 12(3):186-93. PubMed ID: 2977443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial natriuretic factor: pharmacokinetics and cyclic GMP response in relation to biologic effects in severe heart failure.
    Moe GW; Canepa-Anson R; Armstrong PW
    J Cardiovasc Pharmacol; 1992 May; 19(5):691-700. PubMed ID: 1381766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldosterone in congestive heart failure: analysis of determinants and role in sodium retention.
    Hensen J; Abraham WT; Dürr JA; Schrier RW
    Am J Nephrol; 1991; 11(6):441-6. PubMed ID: 1840232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of atrial natriuretic factor [alpha-human ANF-(99-126)] in the hormonal and renal adaptation to sodium deficiency.
    Beland B; Tuchelt H; Bähr V; Oelkers W
    J Clin Endocrinol Metab; 1994 Jul; 79(1):183-8. PubMed ID: 8027224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.